Sources · 208 listed
Sources behind the answers.
Find the sources behind these pages: drug labels, agency records, studies in people, and early studies in cells or animals. Each source shows which peptide reviews use it.
Showing 101–120 of 208 sources
Source types explained
Official records and labels include agency records and product labels. Studies in people test a substance in people. Trial plans and status show planned or ongoing studies; they may not include results. Body changes in people covers studies of how a substance acts in people. Reviews and early studies cover research reviews and studies in cells or animals.
Cattle estrous-cycle resource and FDA-approved animal drugs
FACTREL cattle product label and gonadorelin identity
Wholesale Peptide warning letter
Human drug compounding: FDA questions and answers
Gonadorelin study in hypogonadotropic hypogonadism
Gonadorelin treatment in hypothalamic amenorrhea
Lutrepulse study in women with hypothalamic amenorrhea
Nonrandomized gonadorelin study in congenital hypogonadotropic hypogonadism
GHRP-6 substance identity record (UNII 4H7N4I6X6A)
Growth hormone response to GHRP-6 in healthy men
GHRP-6 growth hormone response and GHRH dependence
GHRP-6 exposure study in healthy men
503A Category 3 bulk drug substances nominated without adequate support
United Pharmacy warning letter
TB-500 substance record
Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin
FDA briefing document for MOTS-c-related bulk drug substances
MOTS-c substance record
About this list
How this list works
This list includes sources used in the peptide reviews. Each source appears once, followed by the reviews that use it. Guide citations stay on their guide pages. A source here may support some claims, not every claim, about a peptide.